Lonza Group AG / Key word (s): Miscellaneous Lonza Implements its Simplified and Streamlined Operating Model 01.04.2025 / 14:00 CET/CEST ...

Lonza Group AG / Key word (s): Share Buyback Lonza Completes its Share Buyback Program 01.04.2025 / 07:00 CET/CEST ...

Lonza, the Swiss Biotech firm that purchased Vacaville’s Genentech plant from Roche in 2024, released a streamlined operating model and invitations to its Annual General Meeting in Basel ...

There are limited tariff risks. Lonza is a potential beneficiary given the ample availability of the USA industrial capacities should biotech or pharma have onshoring needs. With profit growth ...

On Wednesday, Morgan Stanley (NYSE:MS) analysts adjusted their stance on Lonza Group (LONN:SW) (OTC: LZAGY), downgrading the stock from Overweight to Equalweight, while increasing the price target ...

Roche is set to raise $1.2 billion from the sale of a US biologics manufacturing facility to Swiss contract development and manufacturing organisation (CDMO) Lonza, part of a drive to match ...

The issuer is solely responsible for the content of this announcement. Basel, Switzerland, 3 April 2025 – Lonza today announced the publication of its 2024 Annual and Sustainability Reports, as well ...

The extended agreement will expand the dedicated bioconjugation footprint for the customer through the construction of a new bioconjugation suite at Lonza’s Ibex ® Biopark in Visp (CH). In addition, ...